Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation

The treatment of bone metastases is a thorny issue. Immunotherapy may be one of the few hopes for patients with unresectable bone metastases. Immune checkpoint inhibitors are the most commonly used immunotherapy drugs currently. In this review, the characteristics and interaction of bone metastases...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Wang, Miao, Xu, Changli, Li, Bo, Chen, Juxiang, Chen, Jianchun, Wang, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645368/
https://www.ncbi.nlm.nih.gov/pubmed/34877360
http://dx.doi.org/10.1155/2021/8970173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645368/
https://www.ncbi.nlm.nih.gov/pubmed/34877360
http://dx.doi.org/10.1155/2021/8970173

Ejemplares similares